# Canify AG | CATHAROS: New Digital Marketplace for Medical Cannabis in Germany

> **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637)
> **Publisher:** CED Clinic (https://cedclinic.com)
> **Canonical URL:** https://cedclinic.com/canify-ag-catharos-new-digital-marketplace/
> **Published:** 2026-04-14T07:01:20-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:22:24-04:00
> **Clinical Summary:** Explore Canify AG Catharos new digital marketplace transforming medical cannabis access in Germany with innovative clinical relevance.

---

✦ New
CED Clinical Relevance  #76Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely.
⚒ Cannabis News  |  CED Clinic
CanifyAgCatharosNew

Why This Matters

This item covers developments relevant to [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) and [clinical practice](https://cedclinic.com/cannabis-reproductive-health-women-clinical-evidence/). Clinicians monitoring evidence in this area should review the source material.

Clinical Summary
Summary not available. See source for full context.

Dr. Caplan’s Take

“This is a development worth tracking. The clinical implications will become clearer as more evidence accumulates.”

Clinical Perspective
🧠 Clinicians should review this item in the context of their current practice and patient population.

💬 Join the Conversation

Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan)

Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/)

Have thoughts on this? Share it:

[𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Canify%20AG%20%7C%20CATHAROS%3A%20New%20Digital%20Marketplace%20for%20Medical%20Cannabis%20in%20Germany%20%40drcaplan&url=https%3A//www.webdisclosure.com/article/canify-ag-etr-catharos-new-digital-marketplace-for-medical-cannabis-in-germany-rGKLR7F6YsS)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//www.webdisclosure.com/article/canify-ag-etr-catharos-new-digital-marketplace-for-medical-cannabis-in-germany-rGKLR7F6YsS)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Canify%20AG%20%7C%20CATHAROS%3A%20New%20Digital%20Marketplace%20for%20Medical%20Cannabis%20in%20Germany%20--%20via%20%40drcaplan.bsky.social%20https%3A//www.webdisclosure.com/article/canify-ag-etr-catharos-new-digital-marketplace-for-medical-cannabis-in-germany-rGKLR7F6YsS)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/)

📰 Source: [https://www.webdisclosure.com/article/canify-ag-etr-catharos-new-digital-marketplace-for-medical-cannabis-in-germany-rGKLR7F6YsS](https://www.webdisclosure.com/article/canify-ag-etr-catharos-new-digital-marketplace-for-medical-cannabis-in-germany-rGKLR7F6YsS)

 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

Physician-Led, Whole-Person Care
A doctor who takes the time to truly understand you.
Personal care that starts with listening and is guided by experience and ingenuity.

Health, Longevity, Wellness
One-on-One Cannabis Guidance
Metabolic Balance

 [Leave a Message](https://cedclinic.com/contact/)
 [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/)
 [Medical Consulting](https://cedclinic.com/book/)
 [Cannabis Care](https://cedclinic.com/book/)
 

 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

RELATED READING AT CED CLINIC

Continue exploring the evidence

[Canify AG CATHAROS launches: Germany's local marketplace for medical cannabis](https://cedclinic.com/germany-medical-cannabis-marketplace-launch/)

Discover the launch details of Canify AG CATHAROS, a new local marketplace enhancing [medical cannabis access](https://cedclinic.com/medical-marijuana-card-reciprocity/) in Germany.

[Read More](https://cedclinic.com/germany-medical-cannabis-marketplace-launch/)

[Medical Cannabis Significantly Reduced Use of Opioids and Other Rx Drugs](https://cedclinic.com/medical-cannabis-opioid-alternatives-reduce-rx-drug-use/)

Explore research showing how [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) can reduce opioid and prescription drug use, relevant to [clinical practice](https://cedclinic.com/cannabis-reproductive-health-women-clinical-evidence/).

[Learn More](https://cedclinic.com/medical-cannabis-opioid-alternatives-reduce-rx-drug-use/)

[CannaLnx Expands Insured Medical Cannabis Access Across California](https://cedclinic.com/insured-medical-cannabis-access-california-expansion/)

Learn about CannaLnx's expansion of insured medical [cannabis access](https://cedclinic.com/medical-cannabis-delivery-services-growth-dmv-jamaica/), highlighting trends in digital cannabis marketplaces.

[Explore](https://cedclinic.com/insured-medical-cannabis-access-california-expansion/)

 

### Related

---

### Verification & Medical Governance

- **Lead Clinical Author:** Benjamin Caplan, MD
- **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House).
- **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`).
- **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/).
- **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637).
- **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).
